Donovanosis medical therapy

Jump to navigation Jump to search

Donovanosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Classification

Differentiating Donovanosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Donovanosis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Donovanosis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Donovanosis medical therapy

CDC on Donovanosis medical therapy

Donovanosis medical therapy in the news

Blogs on Donovanosis medical therapy

Directions to Hospitals Treating Donovanosis

Risk calculators and risk factors for Donovanosis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]; Nate Michalak, B.A.

Overview

Antimicrobial therapy is the mainstay of treatment for donovanosis. Azithromycin 1 g PO once per week for at least 3 weeks and until all lesions have completely healed is the preferred regimen. Alternative regimens include doxycycline, ciprofloxacin, erythromycin, and trimethoprim-sulfamethoxazole. Pregnant women should be treated with erythromycin. Sexual partners should also be evaluated and treated.

Medical Therapy

  • A limited number of studies on donovanosis treatment have been published.
  • Treatment halts progression of lesions, although prolonged therapy is usually required to permit granulation and reepithelialization of the ulcers.
  • Healing typically proceeds inward from the ulcer margins.
  • Relapse can occur 6–18 months after apparently effective therapy.
  • Several antimicrobial regimens have been effective, but a limited number of controlled trials have been published.[1]

Antimicrobial Therapy

  • Preferred regimen: Azithromycin 1 g PO once per week for at least 3 weeks and until all lesions have completely healed[2]
  • Alternative regimen (1): Doxycycline 100 mg PO bid for at least 3 weeks and until all lesions have completely healed
  • Alternative regimen (2): Ciprofloxacin 750 mg PO bid for at least 3 weeks and until all lesions have completely healed
  • Alternative regimen (3): Erythromycin base 500 mg PO qid for at least 3 weeks and until all lesions have completely healed
  • Alternative regimen (4): Trimethoprim-sulfamethoxazole one double-strength (160 mg/800 mg) tablet PO bid for at least 3 weeks and until all lesions have completely healed
  • Note: The addition of an Aminoglycoside (e.g., Gentamicin 1 mg/kg IV q8h) to these regimens can be considered if improvement is not evident within the first few days of therapy.

Special Considerations

  • Pregnancy: Doxycycline, ciprofloxacin and sulfonamides are contraindicated among pregnant women. Pregnant and lactating women should be treated with the erythromycin or azithromycin regimen, and consideration should be given to the addition of a parenteral aminoglycoside (e.g., gentamicin).
  • HIV coinfection: Individuals with both donovanosis and HIV infection should receive the same regimens as those who are HIV-negative; however, the addition of a parenteral aminoglycoside (e.g., gentamicin) can also be considered.[2]

Follow-Up

Patients should be followed clinically until signs and symptoms resolve.[2]

Treatment of Sex Partners

Persons who have had sexual contact with a patient who has granuloma inguinale within the 60 days before onset of the patient’s symptoms should be examined and offered therapy.

  • Note: the value of empiric therapy in the absence of clinical signs and symptoms has not been established.[2]

Surgical Care

Surgery may be necessary to correct elephantiasis, strictures, or fistulae.

References

  1. O'Farrell N (2002). "Donovanosis". Sex Transm Infect. 78 (6): 452–7. PMC 1758360. PMID 12473810.
  2. 2.0 2.1 2.2 2.3 2015 Sexually Transmitted Diseases Treatment Guidelines. Centers for Disease Control and Prevention (June 4, 2015). http://www.cdc.gov/std/tg2015/donovanosis.htm Accessed March 03 2016


Template:WikiDoc Sources